Allarity Therapeutics, Inc. Contractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations
Allarity Therapeutics, Inc. (ALLR) reported Contractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations of $33.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2024-08-05.
Discontinued › Expense Statement › Interest Expense
us-gaap:ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations · last filed 2024-08-05
- Allarity Therapeutics, Inc. contractual interest expense on prepetition liabilities not recognized in statement of operations for the quarter ending 2023-06-30 was $0.00.
- Allarity Therapeutics, Inc. contractual interest expense on prepetition liabilities not recognized in statement of operations for the quarter ending 2023-03-31 was $33.00K.
| Period end | Contractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations 3 month | Contractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations 6 month |
|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $33.00K 10-Q · filed 2024-08-05 |
| 2023-03-31 | $33.00K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |